Advanced Search

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7) (No. PB 76 of 2013)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 76 of 2013
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated              26             November 2013
 
 
 
 
 
 
 
 
 
FELICITY MCNEILL
 
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7).
         (2)   This Determination may also be cited as PB 76 of 2013.
2              Commencement
                This Determination commences on 1 December 2013.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Albendazole
 
Insert
 
Alogliptin
 
[2]     Schedule 1, after item dealing with Calcium
 
Insert
 
Canagliflozin
 
[3]     Schedule 1, after item dealing with Dabigatran etexilate
 
Insert
 
Dabrafenib
 
[4]     Schedule 1, after item dealing with Dantrolene
 
Insert
 
Dapagliflozin
 
[5]     Schedule 1, after item dealing with Didanosine
 
Insert
 
Dimethyl fumarate
 
[6]     Schedule 1, after item dealing with itraconazole
 
Insert
 
Ivabradine
 
[7]     Schedule 1, after item dealing with Rifampicin
 
Insert
 
Rifaximin
 
[8]     Schedule 1, after item dealing with Terbutaline
 
Insert
 
Teriflunomide
 
 
[9]     Schedule 1, after item dealing with Zidovudine
 
Omit
 
Ziprasidone
 
 
 
[10]   Schedule 2, after item dealing with Vinorelbine
 
Insert
 
Ziprasidone